fadraciclib
cyclacel
['cyc065']
zibo chen presented his research at #aacr23 about how cdk2 inhibition, targeted by cyc065, caused specific chromosome abnormalities in aneuploid cancer cells and disrupted centrosome stoichiometry, a therapeutic strategy against aneuploid cancers. #cancerresearch 
National #biomedical #research resource w/ focus on #cancer, #AIDS, & #infectious diseases. Currently operated by Leidos Biomedical Research for @theNCI.